Covid Vaccine Price
- All
- News
- Videos
-
India Sent Medicine To 150 Countries During Covid Crisis: Health Minister
Union Health Minister Mansukh Mandaviya on Friday said that India sent medicines to 150 countries during covid crisis without increasing the price and compromising on the quality of the medicines.
-
Twitter Accounts Hyped Company Seeking Covid Vaccine Trials: Report
A network of Twitter accounts pushed messages to boost the share price of a biotech company as it sought approval to run a clinical trial of its Covid-19 vaccine, according to research provided to Bloomberg News.
-
At UN, India's Covid Vaccine Swipe At West As It Defends Wheat Export Ban
Voicing concern over the hoarding of food grains and discrimination amid the "unjustified increase" in food prices, the government on Wednesday said that the issue should not go the way of Covid-19 vaccines.
-
Private Hospitals In Delhi, Tamil Nadu Yet To Slash Covid Vaccine Prices
Private hospitals in Tamil Nadu have not slashed the prices of Covid vaccines -- Covishield ad Covaxin -- even though the government has announced a massive reduction.
-
Centre Allows Private Centres To Charge Up To Rs 150 Above Vaccine Price
Centre has told the states that the precaution dose will be of the same COVID-19 vaccine as the one used for the administration of the first two doses. Private vaccine centres can charge Rs 150 per dose as service charge above the cost of vaccine.
-
Coronavirus Highlights: Covishield, Covaxin Prices Cut To Rs 225
The prices of Covishield and Covaxin vaccines at private hospitals have been slashed by more than half. This comes a day before the Covid vaccine booster shots become available to all Indian adults.
-
Can't Afford Price Of Laxity Of Not Vaccinating People: Supreme Court
The Supreme Court on Friday said it cannot just cast doubt on the country's Covid vaccination programme at this crucial stage and cannot afford the price of laxity of not vaccinating people.
-
Merck COVID-19 Pill Has Vital Indian Link, Maker Sees Stock Price Jump
India's Everest Organics Ltd said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of Merck & Co's experimental antiviral drug molnupiravir to treat mild to moderate COVID-19.
-
On High Fuel Prices, Minister Says "You Must Have Taken Free Vaccine"
Union Minister of State for Petroleum and Natural Gas Rameswar Teli has compared the rising price of petrol with that of packaged mineral water and said that the price of such water is more.
-
Zydus Cadila's ZyCoV-D To Be Introduced In Covid Vaccine Drive Shortly: Centre
The government today said Zydus Cadila's indigenously-developed needle-free Covid vaccine ZyCoV-D will be introduced in the nationwide vaccination drive very shortly and will be differentially priced than the jabs being used currently.
-
Talks On To Make Covid DNA Vaccine Part Of Inoculation Drive: Centre
Preparations are on to make Zydus Cadila's COVID-19 DNA vaccine available to people and although the price is a "clear issue", a decision will be taken soon to make it a part of the country's vaccination programme, the government said on Thursday.
-
Google Search, Maps, Assistant Will Now Provide COVID-19 Vaccine Availability, Doses, Cost Details in India
Google Search, Maps, and Assistant in India will now show additional information about vaccine availability and appointments. They will help people get information like availability of slots, expected pricing, information on doses, and more.
-
Zydus Cadila Says "More Clarity" On Its Covid Vaccine Price By Next Week
There will be more clarity on the prices of COVID-19 vaccine ZyCOV-D by next week, Zydus Group Managing Director Dr Sharvil Patel said today.
-
Oil Edges Higher As Tight Supply Outweighs Virus Spread
Oil prices edged higher on Tuesday as investors bet that tight supply and rising vaccination rates will help to offset any impact on demand from surging COVID-19 cases worldwide.
-
Novavax May Get Approval In 2 Months, Likely To Cost More Than Covishield
The Covovax shot developed by American vaccine-maker Novavax would cost a "low single dollar" price per dose but is likely to be costlier than Covishield, company's CEO Stanley Erck said in an exclusive interview.
-
India Sent Medicine To 150 Countries During Covid Crisis: Health Minister
Union Health Minister Mansukh Mandaviya on Friday said that India sent medicines to 150 countries during covid crisis without increasing the price and compromising on the quality of the medicines.
-
Twitter Accounts Hyped Company Seeking Covid Vaccine Trials: Report
A network of Twitter accounts pushed messages to boost the share price of a biotech company as it sought approval to run a clinical trial of its Covid-19 vaccine, according to research provided to Bloomberg News.
-
At UN, India's Covid Vaccine Swipe At West As It Defends Wheat Export Ban
Voicing concern over the hoarding of food grains and discrimination amid the "unjustified increase" in food prices, the government on Wednesday said that the issue should not go the way of Covid-19 vaccines.
-
Private Hospitals In Delhi, Tamil Nadu Yet To Slash Covid Vaccine Prices
Private hospitals in Tamil Nadu have not slashed the prices of Covid vaccines -- Covishield ad Covaxin -- even though the government has announced a massive reduction.
-
Centre Allows Private Centres To Charge Up To Rs 150 Above Vaccine Price
Centre has told the states that the precaution dose will be of the same COVID-19 vaccine as the one used for the administration of the first two doses. Private vaccine centres can charge Rs 150 per dose as service charge above the cost of vaccine.
-
Coronavirus Highlights: Covishield, Covaxin Prices Cut To Rs 225
The prices of Covishield and Covaxin vaccines at private hospitals have been slashed by more than half. This comes a day before the Covid vaccine booster shots become available to all Indian adults.
-
Can't Afford Price Of Laxity Of Not Vaccinating People: Supreme Court
The Supreme Court on Friday said it cannot just cast doubt on the country's Covid vaccination programme at this crucial stage and cannot afford the price of laxity of not vaccinating people.
-
Merck COVID-19 Pill Has Vital Indian Link, Maker Sees Stock Price Jump
India's Everest Organics Ltd said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of Merck & Co's experimental antiviral drug molnupiravir to treat mild to moderate COVID-19.
-
On High Fuel Prices, Minister Says "You Must Have Taken Free Vaccine"
Union Minister of State for Petroleum and Natural Gas Rameswar Teli has compared the rising price of petrol with that of packaged mineral water and said that the price of such water is more.
-
Zydus Cadila's ZyCoV-D To Be Introduced In Covid Vaccine Drive Shortly: Centre
The government today said Zydus Cadila's indigenously-developed needle-free Covid vaccine ZyCoV-D will be introduced in the nationwide vaccination drive very shortly and will be differentially priced than the jabs being used currently.
-
Talks On To Make Covid DNA Vaccine Part Of Inoculation Drive: Centre
Preparations are on to make Zydus Cadila's COVID-19 DNA vaccine available to people and although the price is a "clear issue", a decision will be taken soon to make it a part of the country's vaccination programme, the government said on Thursday.
-
Google Search, Maps, Assistant Will Now Provide COVID-19 Vaccine Availability, Doses, Cost Details in India
Google Search, Maps, and Assistant in India will now show additional information about vaccine availability and appointments. They will help people get information like availability of slots, expected pricing, information on doses, and more.
-
Zydus Cadila Says "More Clarity" On Its Covid Vaccine Price By Next Week
There will be more clarity on the prices of COVID-19 vaccine ZyCOV-D by next week, Zydus Group Managing Director Dr Sharvil Patel said today.
-
Oil Edges Higher As Tight Supply Outweighs Virus Spread
Oil prices edged higher on Tuesday as investors bet that tight supply and rising vaccination rates will help to offset any impact on demand from surging COVID-19 cases worldwide.
-
Novavax May Get Approval In 2 Months, Likely To Cost More Than Covishield
The Covovax shot developed by American vaccine-maker Novavax would cost a "low single dollar" price per dose but is likely to be costlier than Covishield, company's CEO Stanley Erck said in an exclusive interview.
